Animal growth promoters: To ban or not to ban? A risk assessment approach

L. Kelly, D. L. Smith, E. L. Snary, J. A. Johnson, A. D. Harris, M. Wooldridge, J. G. Morris

Research output: Contribution to journalArticle

Abstract

The use of antibiotics for animal growth promotion has been controversial because of the potential transfer of antibiotic resistance from animals to humans. Such transfer could have severe public health implications in that treatment failures could result. We have followed a risk assessment approach to evaluate policy options for the streptogramin-class of antibiotics: virginiamycin, an animal growth promoter, and quinupristin/dalfopristin, a antibiotic used in humans. Under the assumption that resistance transfer is possible, models project a wide range of outcomes depending mainly on the basic reproductive number (R0) that determines the potential for person-to-person transmission. Counter-intuitively, the benefits of a ban on virginiamycin were highest for intermediate values of R0, and lower for extremely high or low values of R0. Crown

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalInternational Journal of Antimicrobial Agents
Volume24
Issue number3
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Virginiamycin
Anti-Bacterial Agents
Growth
Streptogramins
Microbial Drug Resistance
Treatment Failure
Crowns
Public Health

Keywords

  • Animal growth promoters
  • Policy alternatives
  • Risk assessment
  • Streptogramin resistance
  • Uncertainty

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Kelly, L., Smith, D. L., Snary, E. L., Johnson, J. A., Harris, A. D., Wooldridge, M., & Morris, J. G. (2004). Animal growth promoters: To ban or not to ban? A risk assessment approach. International Journal of Antimicrobial Agents, 24(3), 7-14. https://doi.org/10.1016/j.ijantimicag.2004.04.007

Animal growth promoters : To ban or not to ban? A risk assessment approach. / Kelly, L.; Smith, D. L.; Snary, E. L.; Johnson, J. A.; Harris, A. D.; Wooldridge, M.; Morris, J. G.

In: International Journal of Antimicrobial Agents, Vol. 24, No. 3, 09.2004, p. 7-14.

Research output: Contribution to journalArticle

Kelly, L, Smith, DL, Snary, EL, Johnson, JA, Harris, AD, Wooldridge, M & Morris, JG 2004, 'Animal growth promoters: To ban or not to ban? A risk assessment approach', International Journal of Antimicrobial Agents, vol. 24, no. 3, pp. 7-14. https://doi.org/10.1016/j.ijantimicag.2004.04.007
Kelly, L. ; Smith, D. L. ; Snary, E. L. ; Johnson, J. A. ; Harris, A. D. ; Wooldridge, M. ; Morris, J. G. / Animal growth promoters : To ban or not to ban? A risk assessment approach. In: International Journal of Antimicrobial Agents. 2004 ; Vol. 24, No. 3. pp. 7-14.
@article{14b3e4cb036e4043aadb0be61f66e7f1,
title = "Animal growth promoters: To ban or not to ban? A risk assessment approach",
abstract = "The use of antibiotics for animal growth promotion has been controversial because of the potential transfer of antibiotic resistance from animals to humans. Such transfer could have severe public health implications in that treatment failures could result. We have followed a risk assessment approach to evaluate policy options for the streptogramin-class of antibiotics: virginiamycin, an animal growth promoter, and quinupristin/dalfopristin, a antibiotic used in humans. Under the assumption that resistance transfer is possible, models project a wide range of outcomes depending mainly on the basic reproductive number (R0) that determines the potential for person-to-person transmission. Counter-intuitively, the benefits of a ban on virginiamycin were highest for intermediate values of R0, and lower for extremely high or low values of R0. Crown",
keywords = "Animal growth promoters, Policy alternatives, Risk assessment, Streptogramin resistance, Uncertainty",
author = "L. Kelly and Smith, {D. L.} and Snary, {E. L.} and Johnson, {J. A.} and Harris, {A. D.} and M. Wooldridge and Morris, {J. G.}",
year = "2004",
month = "9",
doi = "10.1016/j.ijantimicag.2004.04.007",
language = "English (US)",
volume = "24",
pages = "7--14",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Animal growth promoters

T2 - To ban or not to ban? A risk assessment approach

AU - Kelly, L.

AU - Smith, D. L.

AU - Snary, E. L.

AU - Johnson, J. A.

AU - Harris, A. D.

AU - Wooldridge, M.

AU - Morris, J. G.

PY - 2004/9

Y1 - 2004/9

N2 - The use of antibiotics for animal growth promotion has been controversial because of the potential transfer of antibiotic resistance from animals to humans. Such transfer could have severe public health implications in that treatment failures could result. We have followed a risk assessment approach to evaluate policy options for the streptogramin-class of antibiotics: virginiamycin, an animal growth promoter, and quinupristin/dalfopristin, a antibiotic used in humans. Under the assumption that resistance transfer is possible, models project a wide range of outcomes depending mainly on the basic reproductive number (R0) that determines the potential for person-to-person transmission. Counter-intuitively, the benefits of a ban on virginiamycin were highest for intermediate values of R0, and lower for extremely high or low values of R0. Crown

AB - The use of antibiotics for animal growth promotion has been controversial because of the potential transfer of antibiotic resistance from animals to humans. Such transfer could have severe public health implications in that treatment failures could result. We have followed a risk assessment approach to evaluate policy options for the streptogramin-class of antibiotics: virginiamycin, an animal growth promoter, and quinupristin/dalfopristin, a antibiotic used in humans. Under the assumption that resistance transfer is possible, models project a wide range of outcomes depending mainly on the basic reproductive number (R0) that determines the potential for person-to-person transmission. Counter-intuitively, the benefits of a ban on virginiamycin were highest for intermediate values of R0, and lower for extremely high or low values of R0. Crown

KW - Animal growth promoters

KW - Policy alternatives

KW - Risk assessment

KW - Streptogramin resistance

KW - Uncertainty

UR - http://www.scopus.com/inward/record.url?scp=4344580272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344580272&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2004.04.007

DO - 10.1016/j.ijantimicag.2004.04.007

M3 - Article

AN - SCOPUS:4344580272

VL - 24

SP - 7

EP - 14

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 3

ER -